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Abstract
Background: So far, there have been no measurements confirmed useful in diagnosing acute mountain sickness
(AMS). The aim of this study was to determine the role of heart rate (HR) difference (ΔHR) and oxygen saturation
( SaO2) as objective risk factors in aiding the diagnosis of AMS.
Methods: A total of 1,019 participants were assigned to either the acute exposure group (AEG): from 500 m to
3,700 m by flight within 2.5 h (n = 752); or the pre-acclimatization group (PAG): ascended to 4,400 m from 3,650 m
within three hours by car after adapting 33 days at 3,650 m (n = 267). The questionnaires or measurements of
resting SaO2 (oxygen saturation) and HR were completed between 18 and 24 h before departure and after arrival.
Results: Incidence of AMS was 61.3 % (461) in AEG, with 46.1 % (347) mild cases and 15.2 % (114) severe cases. In
PAG, the incidence was 38.9 % (104), with 30.7 % (82) mild cases and 8.2 % (22) severe cases. The AMS subjects
showed a significant increase in HR and a decrease in SaO2 levels compared with the non-AMS subjects in both
groups. ΔHR and post-exposure SaO2 were significantly correlated with the Lake Louise Score (LLS) in both groups.
Stepwise logistic regression analysis revealed the ΔHR >25 and SaO2 < 88 % in AEG as well as ΔHR >15 and SaO2
< 86 % in PAG to be independent risk factors of AMS. Combining these two measurements could specifically
indicate participants with AMS, which showed a positive predictive value of 89 % and specificity of 97 % in AEG as
well as 85 % and 98 % in PAG.
Conclusion: ΔHR or SaO2, as objective measurements, correlate with AMS. Combination of these two
measurements may be useful as an additional specific and objective factor to further confirm the diagnosis of AMS.
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Background
Travelers may experience acute mountain sickness
(AMS) due to the hypobaric hypoxia that occurs when
individuals are exposed acutely to high altitude (above
2,500 m) or after pre-acclimatization to the same [1, 2].
AMS is a syndrome of non-specific symptoms including
headache, gastrointestinal upset, fatigue, dizziness or in-
somnia that has become an important public health
issue for highland newcomers [3, 4]. If these symptoms
are ignored or the adaptation process fails, AMS may
progress to more severe fatal diseases such as high alti-
tude pulmonary edema (HAPE) or high altitude cerebral
edema (HACE). In addition, it has been suggested that
AMS represents a precursor of HAPE or HACE [2, 5].
Currently, AMS is mainly diagnosed by the Lake Louise
Score (LLS), a subjective symptom questionnaire, which
was established at the International Hypoxia Symposium
at Lake Louise, Canada, 1993 [6]. This diagnosis is not
objective and could increase the probability of misdiag-
nosis. As a result, for undiagnosed AMS, proper treat-
ment including medicines, oxygen and optimized work
plans cannot be used in time to avoid the risk of AMS
progression and to maintain work efficacy. For other
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conditions with similar presentations, this may lead to a
delay in treatment or even unnecessary death. However,
the diagnosis of AMS is clinical and different measure-
ments can only support it, yet there have been no mea-
surements confirmed useful in diagnosing AMS so far.
Hence, finding an objective aided evaluation system for
AMS is crucial.
Many attempts have been made to find physiological
parameters for evaluating AMS. Given that pulse oxim-
etry is a commonly used, noninvasive means of assessing
arterial blood oxygenation, some studies have focused
on this means, in hopes of supporting the assessment of
AMS and have shown that the presence of AMS is sig-
nificantly associated with depressed oxygen saturation
(SaO2) or elevated resting heart rate (HR) [5, 7–9]. Our
previously published data have also shown HR and SaO2
as critical compensatory regulation factors of systemic
oxygen delivery (DO2), correlated with AMS [10]. How-
ever, these measurements have not been confirmed use-
ful in supporting the diagnosis of AMS. First of all, the
exact nature of the correlation between HR, SaO2 and
AMS has yet to be fully elucidated, and the cutoff for
quantifying AMS at a given altitude is not available. Sec-
ondly, resting HR varies widely. In contrast, the differ-
ence of HR between pre-exposure and post-exposure
(ΔHR, post minus pre-exposure) may be more closely
related to the presence of AMS [8]. In addition, most of
the earlier studies were focused on the effect of a single
parameter, but the dynamic and complex nature of AMS
limits its utility in the evaluation of disease. Therefore,
combining some relevant measurements seems to be
more valuable. A predictive index has been proposed by
combining clinical and hematological parameters of
impending AMS [11]. However, the detection of
hematological parameters is invasive. Clearly, further re-
search is needed to establish an objective and simple
noninvasive method to aid the evaluation of AMS.
In this study, we sought to clarify the association be-
tween AMS and ΔHR, SaO2 as well as to determine
their roles, respectively, or in combination in aiding the
evaluation of AMS in the cases of acute and pre-
acclimatized exposure to high altitude.
Methods
Participants
The Ethical Review Board of the Third Military Medical
University approved this study. Study participants were
recruited from Chinese young men living at 500 m. Sub-
jects with known cardiovascular or lung disease, active
infection, or history of exposure to altitude above
3,000 m in the previous three months were excluded
from the study. As a result, a total of 1,019 participants
with an average age of 23 ± 4 years and a mean body
mass index of 21.6 ± 2.1 kg/m2 were enrolled. All
participants signed the informed consent. Subjects were
assigned to two different groups: acute exposure group
(AEG), 752 participants, traveled from 500 m to 3,700 m
by flight within 2.5 h; another group, the pre-
acclimatization group (PAG), composed of 267 partici-
pants, adapted 33 days at an intermediate high altitude
of 3,650 m and then ascended to the destination altitude
of 4,400 m within three hours by car.
Questionnaire and measurement
Structured questionnaires were constructed with the
Lake Louise Questionnaire scoring system and demo-
graphic information (age, weight and height). The ques-
tionnaires were completed under the guidance of
experienced physicians, between 18 and 24 h after arrival
at the destination. Resting SaO2 and HR were measured
by Finger Pulse Oximetry (Nonin Onyx® 9500; Nonin
Medical, Inc.; Plymouth, MN, USA) between 18 and
24 h before departure and after arrival. Participants did
not engage in any physical activity between arrival at
high altitude and study completion. Before the study,
participants were isolated from auditory and visual stim-
uli. Two parameters were measured in triplicate after
the subjects had rested in a seated position for 15 min.
More than 30 colleagues performed the measurement to
ensure it could be done on time. In this study, AMS was
diagnosed as the presence of headache with LLS ≥3, and
the severity of AMS was defined as follows: three to five
indicated mild AMS and six or more points indicated se-
vere AMS [5, 12].
Statistical analysis
Statistical analyses were conducted using SPSS V16.0 for
windows software. To evaluate the differences between
AMS and non-AMS groups, the Mann–Whitney U-test
was applied to compare mean HR and SaO2 (non-nor-
mally distributed variables). The chi-squared test was
performed for analysis of AMS incidence (enumeration
data). To determine the risk factors for AMS, according
to the method mentioned by Martin Burtscher’s study
[13], we used the mean of potentially relevant risk fac-
tors with or without AMS as cutoffs, transformed them
into dummy variables, and then analyzed them by back-
ward stepwise logistic regression using Wald statistic.
The criterion for statistical significance was P < 0.05.
Data were presented as the mean ± SD.
Results
Distribution of demographic date, incidence and severity
of AMS
The characteristics of the demographic data are pre-
sented in Table 1. None of the participants had a clear
history of AMS, known cardiovascular or lung diseases,
or used a preventive medicine such as acetazolamide.
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The distributions of age, body mass index (BMI), and
ethnicity of participants with or without AMS were not
different. The percentage of smokers was marginally
lower in AMS compared with non-AMS, but the differ-
ence was not significant. Interestingly, when combining
two groups together, the Chi-squared test showed smok-
ing was a significant advantage at high altitude and cor-
related significantly with non-AMS (P = 0.004).
The distribution of symptoms or LLS and the inci-
dence or severity of AMS in all subjects are shown in
Fig. 1. The incidence of AMS symptoms except gastro-
intestinal symptoms were significantly higher in AEG
compared with PAG: headache (74 % vs 45 %), dizziness
(72 % vs 56 %), fatigue (71 % vs 60 %) and difficulty
sleeping (64 % vs 32 %). LLS in AEG was mainly distrib-
uted in the intermediate point section (51.2 % with 3–5
points), while, in PAG, it was mostly distributed in the
low point section (53.9 % with 0–2 points). With regard
to the incidence or severity of AMS, 61.3 % (461 of 752)
participants in the AEG were diagnosed with AMS by
the Lake Louise Score System, of which, 46.1 % had mild
AMS and 15.2 % was severe. Whereas, in PAG, the inci-
dences of mild, severe and total AMS were significantly
lower: only 38.9 % (104) had AMS (mild 30.7 %, 82; se-
vere 8.2 %, 22). Of note, none of the participants in ei-
ther group was diagnosed with high altitude pulmonary
edema (HAPE) or high cerebral edema (HACE).
HR and SaO2 responses
The comparisons of HR and SaO2 in participants with
or without AMS in AEG or PAG are presented in
Table 1. The pre-exposure HR and SaO2 did not differ
significantly between AMS and non-AMS participants.
ΔHR was higher in subjects with AMS than without
AMS in both groups. Post-exposure mean HR of the
AMS subjects (86.5 ± 12.1 beats/min) was significantly
higher than that of non-AMS subjects (82.2 ± 10.9 beats/
min) in AEG but not in PAG. In addition, the AMS sub-
jects in both groups also showed a significant decrease
of SaO2 from pre-exposure (ΔSaO2, pre-post) and lower
post-exposure mean SaO2 levels compared with subjects
without AMS. The correlation between various physio-
logical parameters and LLS in all subjects is shown in
Table 2. ΔHR, ΔSaO2 and post-exposure SaO2 were sig-
nificantly correlated with LLS among the study partici-
pants in both groups, while the post-exposure mean HR
was associated with LLS only in AEG but not in PAG.
Variables with a P-value of 0.10 or less were consid-
ered as potentially relevant risk factors for AMS. We
used the mean of HR and SaO2 with or without AMS as
cutoffs and transformed them into dummy variables,
then analyzed them by backward stepwise logistic re-
gression. The results including selected variables in the
model and the odds ratio (OR) were shown in Table 3.
From the results of the regression analysis, in AEG,
ΔHR > 25 and SaO2 < 88 % were revealed to be inde-
pendent predictors of AMS. Likewise, in PAG, a person
with ΔHR > 15 showed two-fold more risk of suffering
AMS than persons with small ΔHR (OR = 2.39, 95 % CI
1.34-4.26, P < 0.01). SaO2 < 86 % also increased the OR
for AMS (OR = 2.86, 95 % CI 1.89-5.89, P < 0.01).
AMS assessment with △HR and SaO2
Because ΔHR > 25 and SaO2 < 88 % in AEG as well as
ΔHR >15 and SaO2 < 86 % in PAG were revealed to be
independent risk factors of AMS, we used these cutoff
Table 1 Distribution of demographic data and clinical parameters between AMS and non-AMS
Parameter AEG (n = 752) PAG (n = 267)
AMS (n = 461) Non-AMS (n = 291) P-value AMS (n = 104) Non-AMS (n = 163) P-value
Age (year) 23.0 ± 3.9 22.8 ± 3.9 0.475 22.2 ± 2.5 21.8 ± 2.3 0.162
BMI (kg/m2) 21.7 ± 2.2 21.8 ± 2.0 0.496 21.2 ± 1.8 21.4 ± 2.6 0.303
Han/ethnicity (%) 87.0 % 88.3 % 0.856 87.7 % 88.9 % 0.737
Medicine use (%) 0 % 0 % 0 % 0 %
Smokers (%) 36.9 % 44.7 % 0.058 36.5 % 47.9 % 0.067
LLS 4.8 ± 1.7 1.6 ± 1.1 0.000 4.5 ± 1.6 1.2 ± 1.2 0.000
HR (pre-exposure) 65.7 ± 9.6 65.7 ± 9.6 0.978 75.6 ± 9.8 78.3 ± 10.6 0.091
HR (post-exposure) 86.5 ± 12.1a 82.2 ± 10.9a 0.003 86.8 ± 12.5a 85.1 ± 10.9a 0.487
△HR (post-pre) 20.9 ± 11.7 16.6 ± 10.6 0.009 11.1 ± 12.0 6.9 ± 9.0 0.010
SaO2 (pre-exposure) 98.10 ± 1.00 98.12 ± 1.02 0.436 91.60 ± 2.31 91.82 ± 2.30 0.45
SaO2 (post-exposure) 88.35 ± 3.23
a 89.38 ± 2.76a 0.008 86.52 ± 2.60a 87.67 ± 2.82a 0.007
△SaO2 (pre-post) 9.75 ± 3.31 8.73 ± 2.89 0.008 5.08 ± 3.13 4.15 ± 2.86 0.010
AMS Acute mountain sickness, AEG Acute exposure group, PAG Pre-acclimatization group, LLS Lake Louise Score, △HR The difference of HR between pre-exposure
and post-exposure, △SaO2 The difference of SaO2 between pre-exposure and post-exposure, Pre-post Pre-exposure minus post-exposure, Post-pre Post-exposure
minus pre-exposure. aP < 0.01 compared with pre-exposure
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values to evaluate the incidence and severity of AMS. As
shown in Fig. 2, in the AEG, when ΔHR > 25 or SaO2 <
88 %, the incidence of severe and total AMS significantly
increased (P < 0.01). In the PAG, a person with ΔHR >15
or SaO2 < 86 % also exhibited an obviously higher inci-
dence of AMS except severe AMS. Furthermore, the
ability to evaluate AMS with these cutoff values is dem-
onstrated by calculating the sensitivity, specificity, posi-
tive and negative predictive values (Table 4). In the AEG,
both ΔHR >25 and SaO2 < 88 % had a certain ability to
evaluate AMS. In particular, the combination of these
two factors increased specificity up to 97 % but de-
creased sensitivity to 16 %. These values cause a positive
predictive value of 89 % and a positive likelihood ratio of
5.33 (Table 4). Similarly, in the PAG, combining ΔHR >
15 and SaO2 < 86 % gives a sensitivity of 16 % and a spe-
cificity of 98 %, which gave a positive predictive value of
85 % and a positive likelihood ratio of 8.0 (Table 4).
Discussion
The present data revealed that ΔHR and SaO2 are ob-
jectively measured correlates of AMS. Combining these
Table 2 Correlation between LLS and various physiological parameters in all subjects
Parameter AEG PAG
Spearman’s Rho P-value Spearman’s Rho P-value
HR (pre-exposure) 0.001 0.973 −0.075 0.222
HR (post-exposure) 0.177 0.000 0.035 0.572
△HR (post-pre) 0.186 0.000 0.128 0.021
SaO2 (pre-exposure) −0.043 0.239 −0.008 0.895
SaO2 (post-exposure) −0.171 0.000 −0.183 0.003
△SaO2 (pre-post) 0.156 0.000 0.147 0.016
AEG Acute exposure group, PAG Pre-acclimatization group, △HR The difference of HR between pre-exposure and post-exposure, △SaO2 The difference of SaO2
between pre-exposure and post-exposure, Pre-post Pre-exposure minus post-exposure, Post-pre Post-exposure minus pre-exposure
Fig. 1 The distribution of symptoms or LLS and the incidence of AMS in AEG and PAG. AMS, Acute mountain sickness; AEG, Acute exposure
group; PAG, Pre-acclimatization group. The comparison was made between AEG and PAG; *: P < 0.01; a P < 0.01 compared with total AMS;
b P < 0.01 compared with severe AMS; c P < 0.01 compared with mild AMS
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two measurements may be useful as additional specific
and objective factors to confirm the presence of AMS.
The result of ΔHR was supported by several previous
studies that showed that the higher resting HR was asso-
ciated with the presence of AMS [8, 9]. However, in this
study, ΔHR was more closely related to the presence of
AMS compared to resting HR. This may be because
resting HR is widely variable due to its vulnerability to
interference, such as barometric pressure or air
temperature. In addition, a major limitation of measur-
ing resting HR and SaO2 are potential behavioral influ-
ences (stimulation, excitement, etc.). The mechanism
behind the ΔHR and AMS association could be related
to a physiologic adaptation to reduce oxygen pressure.
To maintain oxygen delivery to tissues, regulatory re-
sponse in systemic level was performed, which was
mainly embodied by an increase in cardiac output. This
increase is provided primarily by an increase in HR due
to a decrease in stroke volume (SV) [14, 15]. Another
possible explanation for this phenomenon is that an
increase in sympathetic tone is partly relevant to AMS
[16, 17]. As stated previously, the cutoff of ΔHR for
evaluating AMS in AEG is 25, whereas in PAG it is 15.
The "cutoffs" would likely be different for those not ac-
climatized vs. acclimatized at a given altitude and differ-
ent at different altitudes. Thus, more work remains to be
done to clarify these relationships.
We found that SaO2 correlates with the presence of
AMS and could also provide some ability to evaluate
AMS in both groups. It is consistent with many earlier
studies of SaO2 and AMS [7, 8, 17,18]. Only a few inves-
tigations reported a cutoff of SaO2 for evaluating AMS.
In Michael S. Koehel’s study, SaO2 of 86 % or greater
has the potential to rule out AMS, which was given a
negative predictive value of 92 % at 4,380 m [7]. Martin
Burtacher’s study determined the altitude-dependent
SaO2 regression equation for AMS [18]. However, no
one has found a reliable cutoff of SaO2 as a positive indi-
cator of AMS. In this study, we applied the mean of
SaO2 in subjects with AMS as the cutoff, which only
gave a moderate positive predictive value. This unim-
pressive result may be due to the fact that the SaO2 dif-
ference between AMS and non-AMS is small. Taken
together, applying the mean as cutoff is conservative. A
more sensitive cutoff remains to be found as well as the
relationship between the cutoff and destination altitude
in further studies.
As mentioned above, the assessment model made by
combining ΔHR and SaO2 gives a positive predictive
value of 85 % and a specificity of 97 % in AEG and a
positive predictive value of 85 % and a specificity of
98 % in PAG. Our results indicated that it could be help-
ful in identifying AMS in the AEG or the PAG, even
though the two groups experience different exposure
styles and have a different drops in PIO2. Unfortunately,
Table 3 Selected variables and OR of acute mountain sickness
determined by stepwise logistic regression analysis
Selected variables P-value OR (95 % CI)
AEG
△HR (>25 vs ≤17) <0.01 1.86 (1.24-2.79)
SaO2 (<88 % vs >90 %) <0.01 1.72 (1.24-2.38)
HR (>87 vs >82) 0.08 1.38 (0.97-1.97)
PAG
△HR (>15 vs ≤7) <0.01 2.39 (1.34-4.26)
SaO2 (<86 % vs 86 %-88 %) 0.06 1.86 (0.98-3.57)
SaO2 (<86 % vs >88 %) 0.03 2.86 (1.39-5.89)
AEG Acute exposure group, PAG Pre-acclimatization group, △HR The difference
of HR between pre-exposure and post-exposure
Fig. 2 Effect of △HR cutoff (a) or SaO2 cutoff (b) on the AMS incidence. Comparison of AMS incidence between over and below cutoff values of
△HR (a) or SaO2 (b) in AEG and PAG; a: P< 0.01 compared with total AMS; b: P< 0.01 compared with severe AMS; c: P< 0.01 compared with mild AMS
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the ability to screen or rule out AMS was unimpressive
due to its low sensitivity. This indicates that the com-
plexity and dynamic nature of AMS cause the low sensi-
tivity of this model. Another limitation of this approach
is the need for an accurate baseline measurement of in-
dividual resting HR at their low altitude residence and a
similar need for accurate, true resting HR and SaO2 in
the high altitude environment. The inherent nature of a
field study also affected this unimpressive finding. For
example, measurement for a large sample could not be
completed during a strictly narrow period of time. In
addition, other unidentified factors, such as some blood
markers, may be sensitive indicators of AMS. Neverthe-
less, although the sensitivity is very low, at high altitude
the consequences of false positives are still minor; the
measurement of ΔHR and SaO2 is simple and safe, and
this model did specifically identify the AMS participants.
Firstly, if a person scored with AMS by LLS, and ΔHR
and SaO2 were above the cutoff value, it supports more
specifically the AMS diagnosis. Secondly, if a person has
high LLS with a bad headache and is vomiting, but his
ΔHR is elevated less than the cutoff and/or his SaO2 is
above the cutoff, it is also considered AMS, as the LLS
is the primary criteria and high LLS does correlate with
AMS. On the other hand, if a subject claimed not to be
sick and his ΔHR and SaO2 exceeded the cutoffs, he
should be asked more pointedly whether he has had any
symptoms, and be suggested to decrease activity and/or
to take some medicine. If possible, adding the ΔHR and
SaO2 cutoff measures as additional categories to be
scored along with the LLS categories (headache, dizzy,
etc.) might prove to be better than the original LLS, but
this is difficult to prove. Lastly, these study participants
were recruited only from young men due to some diffi-
culties. Women also widely take part in high altitude ac-
tivities including their employment in most of the
world's military activities. The absence of women is cited
as a limitation in the usefulness of these findings which
must be addressed in a further study.
Conclusion
In conclusion, ΔHR or SaO2 do correlate with AMS and
could be somewhat helpful to confirm the presence of
AMS. Combining these two measurements could be
proposed as a specific and objective supplemental factor
in evaluating AMS.
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